ライフサイエンスコーパス: major surgery

1 ication to anticoagulation (active bleeding, major surgery).

2 used as surgical antibiotic prophylaxis for major surgery.

3 ive nonimmunocompromised patients undergoing major surgery.

4 equently used to replace volume losses after major surgery.

5 ed successfully to prevent blood loss during major surgery.

6 roject must report normothermia rates during major surgery.

7 to 725 patients (15.3%) recently underwent a major surgery.

8 obstructive pulmonary disease or undergoing major surgery.

9 e is an independent predictor of death after major surgery.

10 ation of systemic immune responses following major surgery.

11 operfusion, and other factors resulting from major surgery.

12 t in situations that would otherwise require major surgery.

13 rgical candidate and willing to undergo such major surgery.

14 ovide acute postoperative pain control after major surgery.

15 Thirty-one patients were studied after major surgery.

16 ted as a risk factor for adverse outcomes of major surgery.

17 erm dementia risk in older adults undergoing major surgery.

18 seen across a range of situations including major surgery.

19 l, this question is addressed for noncardiac major surgery.

20 patients still experience severe pain after major surgery.

21 se, and pneumonia among older patients after major surgery.

22 use, hospital stay, and complications after major surgery.

23 stent with results from studies on stroke or major surgery.

24 ognostic value of geriatric conditions after major surgery.

25 for patients with serious illness undergoing major surgery.

26 ceiving MB tended to be younger and received major surgery.

27 n complication among older adults undergoing major surgery.

28 HIIT protocols in adult patients undergoing major surgery.

29 ding HIIT in prehabilitation programs before major surgery.

30 who continue vs discontinue RASi use before major surgery.

31 e and chronic postsurgical pain (CPSP) after major surgery.

32 are strategy to reduce AKI within 72 h after major surgery.

33 ostoperative outcomes in patients undergoing major surgery.

34 g protocols to shorten hospitalization after major surgery.

35 ntially reducing the physiological impact of major surgery.

36 ions on clinical and economic outcomes after major surgery.

37 ween SNH status and 30-day readmission after major surgery.

38 renal dysfunction and 90-day mortality after major surgery.

39 evention of infection in patients undergoing major surgery.

40 (AKI) or chronic kidney disease (CKD) after major surgery.

41 ined pathway but with similar proportions of major surgery.

42 rse outcomes for elderly patients undergoing major surgery.

43 ess in patients who are being considered for major surgery.

44 diac injury and support rapid recovery after major surgery.

45 e incidence of morbidity and mortality after major surgery.

46 Prevalence of neuropathic pain is high after major surgery.

47 is was rated as excellent or good during all major surgeries.

48 cant noise exposure, middle-ear problems, or major surgeries.

49 Of older US patients undergoing major surgery, 1 in 4 is readmitted to a hospital other

50 18,461 patients in ENDORSE who had undergone major surgery, 17,084 (92.5%) were at-risk for VTE and 1

51 ries and procedures (7 vs. 41; P < .01), and major surgeries (2 vs. 11; P < .05), compared with those

52 ommon indication for massive transfusion was major surgery (61.2%) followed by trauma (15.4%).

53 [52.5%]) with inpatient hospitalizations for major surgery, 70 752 (2.0%) were Asian, 453 428 (13.1%)

54 A total of 2186 infants underwent major surgery, 784 had minor surgery, and 9141 infants d

55 Among adults at high risk for AKI undergoing major surgery, a preventive care strategy consisting of

56 Smoking cessation at least 1 year before major surgery abolishes the increased risk of postoperat

57 e-center cohort of patients discharged after major surgery, AKI with even small changes in sCr level

58 Hospital readmissions are common after major surgery, although it is unknown whether patients a

59 on were consistent across different types of major surgery, although there was notable heterogeneity

60 ion-based estimate of 1-year mortality after major surgery among community-living older adults in the

61 Major surgeries and mortality over 1 year were identifie

62 e performance of all VA hospitals performing major surgery and anonymously compares these hospitals u

63 IL-6 levels increase after a major surgery and are associated with an increased susce

64 tal cancer managed by watch and wait avoided major surgery and averted permanent colostomy without lo

65 urs in 10% to 60% of elderly patients having major surgery and is associated with longer hospital sta

66 ge frequently occurs during sepsis and after major surgery and is associated with microvascular dysfu

67 icts events in cirrhotic subjects undergoing major surgery and may offer similar prognostication in l

68 ncluding liver injury and regeneration after major surgery and preservation of the organ during trans

69 se 1-year mortality in older patients having major surgery and randomly assigned to light or deep gen

70 32 adults aged 60 years and older undergoing major surgery and receiving general anesthesia at Barnes

71 ery of premorbid function within 6 months of major surgery and second, to identify factors associated

72 ated that plasma levels would increase after major surgery and that such elevations may facilitate tu

73 escalate towards chemotherapy followed by a major surgery and therefore is a high-stakes task for th

74 bout variation in rates of readmission after major surgery and whether these rates at a given hospita

75 the general surgical population (eg, age and major surgery) and transplant-specific factors (eg, neur

76 of pelvic or lower extremity fractures, and major surgery), and the points total is converted to a V

77 omyalgia, rheumatological conditions, recent major surgery, and history of substance abuse, alcohol a

78 ery of premorbid function within 6 months of major surgery, and identified factors associated with fu

79 not decrease delirium in older adults after major surgery, and might cause harm by inducing negative

80 Sepsis, major surgery, and nephrotoxic drugs are the most common

81 For patients who had major surgery, any statement related to ACP from the sur

82 for postoperative pain (POP), ~ 310 million major surgeries are performed globally per year.

83 Patients undergoing major surgery are at high risk of increased postoperativ

84 Patients undergoing major surgery are at risk of life-threatening inflammato

85 Wide variations in mortality after major surgery are becoming increasingly apparent.

86 ostoperative outcomes in patients undergoing major surgery are not fully established.

87 Clinical outcomes after major surgery are poorly described at the national level

88 Our data suggest that the risks of major surgery are substantially higher in nursing home r

89 ative mortality and long-term survival after major surgery as exemplified by 8 common operations.

90 might be an indicator of inflammation after major surgery, as well as an anti-inflammatory therapy r

91 ognitive decline is an adverse outcome after major surgery associated with increased risk for mortali

92 mode of delivery, gestational age at birth, major surgery, asthma diagnosis, chronic conditions, and

93 mmunicate verbally, and scheduled to undergo major surgery at 1 of 2 Harvard-affiliated hospitals wit

94 y of 188,212 patients undergoing nonemergent major surgery at 124 Veterans Affairs hospitals from 200

95 Patients (aged >=18 years) undergoing major surgery at high risk for AKI identified by predefi

96 Clinical Database for patients who underwent major surgery at hospitals in the US between January 1,

97 Patients undergoing major surgery at minority-serving hospitals also had hig

98 atients aged 65 years or older who underwent major surgery at US hospitals within 7 days of hospital

99 c kidney disease who were discharged after a major surgery between 1992 and 2002.

100 ng 161,185 United States veterans undergoing major surgery between 2004 and 2011, we characterized in

101 470 905 adult inpatient hospitalizations for major surgery between January 1, 2018, and October 31, 2

102 has been shown to reduce complications after major surgery, but strong evidence to recommend its rout

103 ated with increased hospital costs following major surgery, but the mechanism by which they increase

104 tasis was rated as excellent/good in 100% of major surgeries by the investigator.

105 Major surgeries can result in high rates of adverse post

106 ries resulting from trauma, acute illness or major surgery can take several weeks to heal, generally

107 Because major surgery carries significant risks for older adults

108 For patients who had major surgery compared with those who had no surgery, th

109 Among survivors who had major surgery compared with those who had no surgery, th

110 from a cohort of elderly patients undergoing major surgery, comparing samples collected at baseline t

111 ely recommended to patients discharged after major surgery despite no clear evidence that it improves

112 ithhold transfer to the intensive care unit, major surgery, dialysis, blood transfusion, vasopressors

113 e coagulation status in numerous conditions: major surgery (e.g., heart, vascular, hip fracture, and

114 Among older adults undergoing major surgery, EEG-guided anesthetic administration, com

115 et transfusion before invasive procedures or major surgery (eg, laparotomy).

116 sease progression, defined as a composite of major surgery, endoscopic excision of advanced adenomas,

117 Misdiagnosis of AIP can result in major surgery for a steroid-responsive disease.

118 ther group died from hemorrhage or underwent major surgery for bleeding complications.

119 All patients who underwent major surgery for cancer of the bladder, breast, colon o

120 and ramifications of geriatric events during major surgery for cancer.

121 ectal cancer was oncologically equivalent to major surgery for carcinoma in situ and T1 rectal cancer

122 We created a model to estimate rates of major surgery for countries for which such data were una

123 ide or lenalidomide; (3) patients undergoing major surgery for malignant disease should be considered

124 Other predictors included major surgeries, fractures (IRR=2.81), immobility (IRR=4

125 US aged 65 years or older who had at least 1 major surgery from 2011 to 2018.

126 udy of 8967 schizophrenic patients receiving major surgery from the Taiwan National Health Insurance

127 From 2011 to 2017, of the 1193 major surgeries (from 992 community-living participants)

128 This study tests the hypothesis that major surgery has a more profound effect on plasma level

129 gery and much of the available evidence from major surgery has been assembled over the many years tha

130 the 30-day mortality and morbidity rates for major surgery have fallen 9% and 30%, respectively.

131 tial predictors of functional recovery after major surgery have, however, not been well-studied among

132 ple who lived further than 60 minutes from a major surgery hospital decreased (P<0.001).

133 791; 2015, n = 3391; P<0.001), the number of major surgery hospitals increased from 2005 (n = 539) to

134 nd high resource use in patients who undergo major surgery; however, their interrelationship is not w

135 mortality among 1445 patients who underwent major surgery (HR, 1.1; 95% CI, 0.71-1.77).

136 30 days after surgery on veterans undergoing major surgery in 123 medical centers; development of mul

137 a result of PET findings, physicians avoided major surgery in 41% of patients for whom surgery was th

138 Intravenous nutrition as an alternative to major surgery in Crohn disease should be considered.

139 tial predictors of functional recovery after major surgery in geriatric patients have not been well-s

140 Information about use of major surgery in India is scarce.

141 Poorer outcomes after major surgery in males and shorter ALPPS interstage inte

142 rbidity, allow esophageal healing, and avoid major surgery in most patients.

143 t to mortality, July is a safe month to have major surgery in teaching hospitals in the United States

144 s (HOV) to in-hospital mortality (IHM) after major surgery in the United States (US).

145 ve factors in determining the survival after major surgery in the VA.

146 ed fashion by a dedicated nurse reviewer, on major surgery in the Veterans Administration (VA).

147 Major surgery in very low-birth-weight infants is indepe

148 Major surgery includes any intervention within an operat

149 al readmissions within 30 and 180 days after major surgery, including both fee-for-service and Medica

150 Immunosuppression after major surgery increases the risk of infections.

151 Major surgery induces a quantifiable pattern of gene exp

152 re hospitalized for a proinflammatory event (major surgery, infection, or vascular event).

153 Among adult patients undergoing major surgery, intraoperative ventilation with low tidal

154 Morbidity after major surgery is associated with low oxygen delivery.

155 Major surgery is associated with profound alterations in

156 n on whether the iatrogenic injury caused by major surgery is associated with similar patterns.

157 Rehospitalization after major surgery is common and represents a significant cos

158 Myocardial infarction after major surgery is frequent, drives outcome, and consumes

159 However, IHM after major surgery is multifactorial, and the relative contri

160 Weekend discharge after major surgery is not associated with higher 30- or 90-da

161 its role in anesthetized patients undergoing major surgery is not known.

162 contribution of PC, HC, and HOV to IHM after major surgery is unknown.

163 gery (vulvectomy) and 13 patients undergoing major surgery (laparotomy) were prospectively followed u

164 k of postoperative kidney injury) undergoing major surgery lasting 2 hours or longer under general an

165 nts at increased risk of complications after major surgery, light general anaesthesia was not associa

166 nology and type of early complications after major surgery may alert clinicians when to expect higher

167 perative hypothermia, which is common during major surgery, may promote surgical-wound infection by t

168 to regular hospital floors after nonemergent major surgery, mortality is increased if surgery is perf

169 ysicians to consider VTE prophylaxis include major surgery, multiple trauma, hip fracture, or lower e

170 t predictors for stop/switch of ADP blocker: major surgery, need for oral anticoagulation (OAC), TIMI

171 n health care have an estimated mean rate of major surgery of 295 (SE 53) procedures per 100 000 popu

172 Patients undergoing major surgery often receive PRBC transfusions.

173 count targets (90 x 10(9) cells per L before major surgery or 45 x 10(9) cells per L before minor sur

174 The risk of developing VTE is highest after major surgery or a major injury, or when someone has hea

175 low-dose aspirin treatment in the absence of major surgery or bleeding is likely an important treatme

176 uation of low-dose aspirin in the absence of major surgery or bleeding was associated with a >30% inc

177 th aspirin discontinuation in the absence of major surgery or bleeding.

178 a sustained hemostatic correction because of major surgery or bleeding.

179 nts less than 100 x 10(9) cells per L before major surgery or less than 50 x 10(9) cells per L before

180 due to these acquired disorders or following major surgery or trauma.

181 Two to 4 weeks of cessation before planned major surgery or withdrawal of anticoagulants in patient

182 ily as a complication of hospitalization for major surgery (or associated with the late stage of term

183 verse events, defined as hospital admission, major surgery, or blood transfusion.

184 on on assisted ventilation or no surgery; B, major surgery; or C, cardiac surgery requiring bypass.

185 Achievements in modern medicine, such as major surgery, organ transplantation, treatment of prete

186 and devices; however, in patients undergoing major surgery, other risks such as mortality compete wit

187 n underdiagnosed, serious complication after major surgery, particularly in the elderly population.

188 Among infants undergoing major surgery, postoperative use of intermittent intrave

189 ictors of stroke or death included impending major surgery, previous stroke, age, symptomatic lesion,

190 and adaptive cell signaling dynamics after a major surgery (primary outcome) in patients treated with

191 s is a risk factor for SCI in other types of major surgery, SCI is not widely recognized in transplan

192 Patients undergoing major surgery should receive prophylaxis starting before

193 the resident being the operating surgeon in major surgeries, substantial citing of evidence-based li

194 the preferences of older adults considering major surgery, surgeon use of shared decision-making is

195 For patients facing major surgery, surgeons believe preoperative advance car

196 f mortality and invasive interventions after major surgery than other Medicare beneficiaries that are

197 injury (PO-AKI) is a common complication of major surgery that is strongly associated with short-ter

198 , restricted-volume fluid administration for major surgery, there remains little consensus on optimal

199 141 (66%) did not have an AD on file before major surgery; there was no significant association betw

200 at provides access to free tertiary care for major surgery through state-funded insurance to 68 milli

201 the complex healing process occurring after major surgery, thus directly affecting the surgical outc

202 rmation for 46,299 adult patients undergoing major surgery to develop a multivariable probabilistic m

203 ho had increased risk of complications after major surgery to receive light general anaesthesia (bisp

204 association with transient risk factors (eg, major surgery, trauma, pregnancy) have a low annual recu

205 inolytic agents to prevent blood loss during major surgery/trauma.

206 Use of prophylaxis varied according to major surgery type from 86.0% for orthopedic surgery to

207 Despite near universal access for major surgery, use continues to remain low, at levels ex

208 siology with overall ability to recover from major surgery, using novel approaches such as analytic m

209 increased home time in the first year after major surgery was associated with improved daily functio

210 or replacement of fluid losses on the day of major surgery was associated with less postoperative mor

211 Major surgery was defined as any intervention occurring

212 hospital readmissions within 180 days after major surgery was increased among older persons who were

213 e communication for older adults considering major surgery was performed at 5 US academic medical cen

214 e cohort of opioid-naive patients undergoing major surgery, we found a number of characteristics asso

215 A total of 2,854,810 hospitalizations for major surgeries were included in this study.

216 Patients undergoing major surgery were at increased risk for mortality up to

217 Patients aged >or=18 years undergoing major surgery were included in this prespecified subanal

218 disease, whereas receipt of chemotherapy and major surgery were not.

219 of lipid formulations of amphotericin B and major surgery when feasible as the most appropriate firs

220 argeted procedures, eliminating the need for major surgery, while others could undergo procedures for

221 hypothalamic-pituitary-adrenal responses to major surgery will provide us with a more rational appro

222 eved by pain medications and may necessitate major surgeries with high morbidity and mortality.

223 eneficiaries 66 years old and older who have major surgery with and without prolonged mechanical vent

224 on-admissions in which participants survived major surgery with increased disability and were monitor

225 l recovery among older persons who survive a major surgery with increased disability.

226 l recovery among older persons who survive a major surgery with increased disability.

227 Pancreas transplantation remains a major surgery with potential complications that require

228 g remains one of the most commonly performed major surgeries, with well-established symptomatic and p

229 on criteria included patients undergoing any major surgery, with a sample size of at least 100 patien

230 pheral neuropathy with grade greater than 1, major surgery within 4 weeks before enrolment, known CNS

231 ERAS recommendations for patients undergoing major surgery within an ERAS protocol.

232 luded vaginal bleeding, blood transfusion or major surgery within the past 3 months, symptomatic anae

233 f the total surgical workload and 90% of the major surgery workload.

234 Cesarean section (CS) is the most common major surgery worldwide and, by enabling birth outside p

235 I) is a common and important complication of major surgery, yet recommended preventive care is rarely